| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5504755 | Biochemical and Biophysical Research Communications | 2017 | 7 Pages |
Abstract
The current study provides evidence that a large subgroup of human glioblastomas are highly glycolytic, and that inhibitors of glycolysis, like LDHA targeting agents, may prove of therapeutic importance by enhancing the efficacy of radiotherapy and temozolomide against this lethal disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Michael Koukourakis, Avgi Tsolou, Stamatia Pouliliou, Ioannis Lamprou, Maria Papadopoulou, Maria Ilemosoglou, Georgia Kostoglou, Dimitra Ananiadou, Efthimios Sivridis, Alexandra Giatromanolaki,